FDA Reinstates GSK’s Leucovorin, Reviving RFK Jr.’s Autism Treatment Claims
FDA Reinstates GSK’s Leucovorin, Reviving RFK Jr.’s Autism Treatment Claims The U.S. Food and Drug Administration (FDA) has reportedly reinstated the availability of GSK’s leucovorin drug, a decision that has put the medication back in the spotlight, particularly due to its controversial endorsement by prominent political figure RFK Jr. RFK Jr. has publicly touted leucovorin as a potential treatment for autism, a claim that remains largely unsupported by mainstream medical and scientific consensus. Leucovorin, primarily utilized to mitigate the toxic…